Cargando…

Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts

BACKGROUND: The post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chongyu, He, Chaobin, Lu, Jiawei, Huang, Xin, Chen, Cheng, Lin, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033166/
https://www.ncbi.nlm.nih.gov/pubmed/35463346
http://dx.doi.org/10.3389/fonc.2022.832038
_version_ 1784692823052779520
author Zhao, Chongyu
He, Chaobin
Lu, Jiawei
Huang, Xin
Chen, Cheng
Lin, Xiaojun
author_facet Zhao, Chongyu
He, Chaobin
Lu, Jiawei
Huang, Xin
Chen, Cheng
Lin, Xiaojun
author_sort Zhao, Chongyu
collection PubMed
description BACKGROUND: The post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for predicting PPS in recurred iCCA patients. METHOD: Clinical characteristics were retrospectively collected in 396 patients diagnosed with iCCA from cohorts of Sun Yat-sen University Cancer Center (SYSUCC) and the First Hospital of Dalian Medical University (FHDMU). The PPS in patients with different progression patterns was investigated. The nomogram of PPS was established with the Cox regression model in the primary cohort. Then the nomogram was verified in the external validation cohort. RESULTS: Liver progression was the commonest pattern (42.08%) in recurred iCCA patients, while patients with local LN progression had significantly better PPS than those with other patterns. The independent prognostic factors comprised elevated CEA levels, tumor differentiation, N stage 8th, adjuvant therapy, Local LN metastasis, Liver Metastasis only, and Multiple Metastasis. The nomogram constructed on these factors achieved satisfied C-indexes of 0.794 (95% CI 0.769–0.828) and 0.827 (0.779–0.876) for the training and validation cohorts, respectively. These values were significantly higher than those of the 8th TNM stage system (all p < 0.001). The recurred iCCA patients could be precisely classified into high- and low-risk groups according to the cutoff point of this nomogram (p < 0.01). CONCLUSION: The investigation of progression patterns and the development of this nomogram can offer new evidence to precisely postoperative and post-progression management of iCCA patients.
format Online
Article
Text
id pubmed-9033166
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90331662022-04-23 Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts Zhao, Chongyu He, Chaobin Lu, Jiawei Huang, Xin Chen, Cheng Lin, Xiaojun Front Oncol Oncology BACKGROUND: The post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for predicting PPS in recurred iCCA patients. METHOD: Clinical characteristics were retrospectively collected in 396 patients diagnosed with iCCA from cohorts of Sun Yat-sen University Cancer Center (SYSUCC) and the First Hospital of Dalian Medical University (FHDMU). The PPS in patients with different progression patterns was investigated. The nomogram of PPS was established with the Cox regression model in the primary cohort. Then the nomogram was verified in the external validation cohort. RESULTS: Liver progression was the commonest pattern (42.08%) in recurred iCCA patients, while patients with local LN progression had significantly better PPS than those with other patterns. The independent prognostic factors comprised elevated CEA levels, tumor differentiation, N stage 8th, adjuvant therapy, Local LN metastasis, Liver Metastasis only, and Multiple Metastasis. The nomogram constructed on these factors achieved satisfied C-indexes of 0.794 (95% CI 0.769–0.828) and 0.827 (0.779–0.876) for the training and validation cohorts, respectively. These values were significantly higher than those of the 8th TNM stage system (all p < 0.001). The recurred iCCA patients could be precisely classified into high- and low-risk groups according to the cutoff point of this nomogram (p < 0.01). CONCLUSION: The investigation of progression patterns and the development of this nomogram can offer new evidence to precisely postoperative and post-progression management of iCCA patients. Frontiers Media S.A. 2022-04-08 /pmc/articles/PMC9033166/ /pubmed/35463346 http://dx.doi.org/10.3389/fonc.2022.832038 Text en Copyright © 2022 Zhao, He, Lu, Huang, Chen and Lin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhao, Chongyu
He, Chaobin
Lu, Jiawei
Huang, Xin
Chen, Cheng
Lin, Xiaojun
Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts
title Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts
title_full Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts
title_fullStr Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts
title_full_unstemmed Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts
title_short Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts
title_sort progression patterns and post-progression survival in recurred intrahepatic cholangiocarcinoma patients: a novel prognostic nomogram based on multicenter cohorts
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033166/
https://www.ncbi.nlm.nih.gov/pubmed/35463346
http://dx.doi.org/10.3389/fonc.2022.832038
work_keys_str_mv AT zhaochongyu progressionpatternsandpostprogressionsurvivalinrecurredintrahepaticcholangiocarcinomapatientsanovelprognosticnomogrambasedonmulticentercohorts
AT hechaobin progressionpatternsandpostprogressionsurvivalinrecurredintrahepaticcholangiocarcinomapatientsanovelprognosticnomogrambasedonmulticentercohorts
AT lujiawei progressionpatternsandpostprogressionsurvivalinrecurredintrahepaticcholangiocarcinomapatientsanovelprognosticnomogrambasedonmulticentercohorts
AT huangxin progressionpatternsandpostprogressionsurvivalinrecurredintrahepaticcholangiocarcinomapatientsanovelprognosticnomogrambasedonmulticentercohorts
AT chencheng progressionpatternsandpostprogressionsurvivalinrecurredintrahepaticcholangiocarcinomapatientsanovelprognosticnomogrambasedonmulticentercohorts
AT linxiaojun progressionpatternsandpostprogressionsurvivalinrecurredintrahepaticcholangiocarcinomapatientsanovelprognosticnomogrambasedonmulticentercohorts